Multi-center, Randomized, Double-blind, Placebo-controlled Trial to Evaluate the Effects of Intra-Erythrocyte Dexamethasone Sodium Phosphate on Neurological Symptoms in Patients With Ataxia Telangiectasia
Latest Information Update: 06 Sep 2024
At a glance
- Drugs Dexamethasone (Primary)
- Indications Ataxia telangiectasia
- Focus Registrational; Therapeutic Use
- Acronyms ATTEST; ATTeST
- Sponsors EryDel; Quince Therapeutics
- 01 Sep 2024 Results assessing evaluating the efficacy and safety of intra-erythrocyte delivery of dexamethasone sodium phosphate compared with placebo in children with ataxia telangiectasia were published in the Lancet Neurology.
- 15 Aug 2024 According to a Quince Therapeutics media release, data from the study were presented in The Lancet Neurology
- 15 Aug 2024 Results presented in the Quince Therapeutics Media Release